Immune Defense Mechanisms at the Mucosa Cooperative Study Group (U01)

Post Date

April 23rd 2010

Application Due Date

October 22nd 2010

Funding Opportunity Number

RFA-AI-10-008

CFDA Number(s)

93.855

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $4000000

• Award Range:

  $None - $None

Grant Description

Purpose. The National Institute of Allergy and Infectious Diseases (NIAID) invites applications from institutions/organizations to participate in a cooperative study group focused on immune defense mechanisms and immune regulation at mucosal surfaces including respiratory, gastrointestinal and urogenital tract mucosa. The goal is to break new ground in the understanding of basic mucosal immune defense mechanisms by introducing new ideas, approaches and technologies that address the difficult questions remaining in mucosal immune defense. The knowledge gained would facilitate future development of vaccines and immunotherapies to protect mucosal surfaces from infection and related immunopathologies. The cooperative study group will be composed of a set of cooperative agreement grants governed by a Steering Committee, and will draw upon an Infrastructure and Opportunities Fund to support a range of innovative, collaborative, and pilot/feasibility projects. NIAID encourages submissions from established and new investigators; applicants without a prior track record of funding in mucosal immunity are welcome to apply. Mechanism of Support. This FOA will utilize the cooperative agreement (U01) award mechanism. Funds Available and Anticipated Number of Awards. For this funding opportunity, budgets up to $250,000 direct costs per year and time periods up to five years may be requested. NIAID expects to allocate approximately $4 million in total costs in FY 2011 to fund seven to nine awards.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-10-008.html